1
110 Communications libres Ann. Endocrinol. été déjà montré que l’efflux du cholestérol cellulaire (cellules FU5AH) est altéré chez les patients diabétiques de type 2, nous avons voulu vérifier si, en présence d’une coronaropathie, cette altération serait modulée. Pour cela, trois groupes de sujets ont été comparés : té- moins (T : n = 7), diabétiques (D : n = 9) et diabétiques cardiaques (DC : n = 9). Les résultats montrent que les patients DC ont une tri- glycéridémie élevée par rapport à celle des T et des D (respectivement : 2,6 ± 0,7 ; 1,4 ± 0,5 ; 2,0 ± 0,7 mmo- les/l, p < 0.01). Le C-HDL est plus bas chez les patients DC quant à celui des T (p < 0,05) et des D (NS), alors que les concentrations des phospholipides-HDL restent compara- bles dans les trois groupes. La mesure de la capacité du sé- rum à promouvoir le cholestérol cellulaire montre que, comme attendu, les patients D ont un efflux significati- vement moins important que celui des T (p < 0.05). Par contre, l’efflux chez les sujets DC est non significative- ment différent de celui des T (T : 28,4 ± 4,2 ; D : 22,1 ± 5,5 ; DC : 27,3 ± 5,7 %). Aucune corrélation n’a été trouvée entre le niveau de l’efflux du cholestérol et l’état glycémique (glycémie et HbA1c) ainsi que la compo- sition des HDL. Ces résultats suggèrent que : 1) l’altération du l’efflux dans le diabète de type 2 est indépendant de l’équilibre glycémique ainsi que de la composition HDL en phos- pholipides ; 2) le rétablissement de l’efflux chez les pa- tients DC à des valeurs comparables à celles des témoins pourrait être favorisé par leur hypertriglycéridémie géné- rant des particules de prébéta-HDL, connues par leur pouvoir élevé à capter le cholestérol à partir des cellules périphériques. EFFECTS OF CHOLINERGIC BLOCKADE BY PIRENZEPINE ON INSULIN AND GLUCOSE RESPONSE TO ORAL GLUCOSE IN OBESE PRE-MENOPAUSAL WOMEN C013 F. Vignati (1) , O. Disoteo (1) , G. Di Sacco (1) (1) Divisione di Endocrinologia, Ospedale Niguarda, piazza Ospedale Maggiore 3 -20162- Milano Italia. e-mail : [email protected] Parasympathetic nervous system is known to affect in- sulin secretion in animal and in humans. Pirenzepine, a selective muscarinic cholinergic antagonist, reduces plasma insulin and plasma glucose responses in normal humans. We studied the effects of pirenzepine on plasma insulin and glucose responses to standard (75g) oral glucose tolerance test (OGTT) in 6 obese pre-meno- pausal women (BMI range=30,50-32,68Kg/m 2 , age range 28-35-years). Patients underwent, in random se- quence after an overnight fast and on two separate oc- casions, OGTT alone or OGTT preceded by pirenzepine 100mg, 60 minutes before starting OGTT. Blood samples were collected at –30min and 0min and, subsequently, every 15 minutes for 2 hours. Results: The mean insulin response to OGTT (expressed as area under the curve, AUC) was significantly reduced after pirenzepine administration (insulin AUC=7297±3160mcU/ 120min vs 10913±3290 p<0.05). After pirenzepine insulin levels were significantly reduced at time -30 (10.2±5mcU/ mL vs 14.8±6.2; p<0.01) and insulin and glucose levels were both significantly reduced at time 0’(11.8±4.9mcU/ mL vs 15.2±6.2; p<0.05 and 85.8±10mg/dL vs 91.5±13.7; p<0.02 respectively) in comparison to the control day. In two patients we also measured plasma glucagon-like pep- tide (GLP-1) levels and in both cases a reduced response of the hormone after OGTT was observed when the test was preceded by pirenzepine administration. Conclusions: The present study confirms that the cho- linergic system plays a role in the exaggerated insulin se- cretion in obese subjects. Interestingly the reduction of insulin secretion induced by pirenzepine was not fol- lowed by worsening of glucose response to OGTT. This finding might be consistent with the existence of indi- rect mechanisms, probably involving GLP-1 secretion pa- thways. 479 — 23/01/04 — Federico1074855390. PLASMA AMINO ACID PATTERN CAN BE INFLUENCED BY AGE AND DIABETES C014 G. Di Sacco (1) , R. Accinni (2) , C. Della Noce (2) , F. Muratori (1) (1) Divisione di Endocrinologia, Ospedale Niguarda, Milan, Italy. e-mail : [email protected] (2) Institute of Clinical Physiology, CNR Sezione di Milano, Niguarda Hospital, Milan, Italy. It is well known that age and diabetes may affect pro- tein metabolism, but few data are so far available on plasma amino acid pattern (AAP) in these conditions. The present study was performed to search for differences, if any, in AAP in adult young and elderly subjects with or without diabetes. We measured, by HPLC, morning plasma amino acid pattern after an overnight fast, in 4 groups of subjects.

C013 - Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral glucose in obese pre-menopausal women

  • Upload
    g

  • View
    218

  • Download
    3

Embed Size (px)

Citation preview

Page 1: C013 - Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral glucose in obese pre-menopausal women

110

Communications libres Ann. Endocrinol.

été déjà montré que l’efflux du cholestérol cellulaire(cellules FU5AH) est altéré chez les patients diabétiquesde type 2, nous avons voulu vérifier si, en présenced’une coronaropathie, cette altération serait modulée.Pour cela, trois groupes de sujets ont été comparés : té-moins (T : n = 7), diabétiques (D : n = 9) et diabétiquescardiaques (DC : n = 9).Les résultats montrent que les patients DC ont une tri-glycéridémie élevée par rapport à celle des T et des D(respectivement : 2,6 ± 0,7 ; 1,4 ± 0,5 ; 2,0 ± 0,7 mmo-les/l, p < 0.01). Le C-HDL est plus bas chez les patients DCquant à celui des T (p < 0,05) et des D (NS), alors que lesconcentrations des phospholipides-HDL restent compara-bles dans les trois groupes. La mesure de la capacité du sé-rum à promouvoir le cholestérol cellulaire montre que,comme attendu, les patients D ont un efflux significati-

vement moins important que celui des T (p < 0.05). Parcontre, l’efflux chez les sujets DC est non significative-ment différent de celui des T (T : 28,4 ± 4,2 ; D :22,1 ± 5,5 ; DC : 27,3 ± 5,7 %). Aucune corrélation n’aété trouvée entre le niveau de l’efflux du cholestérol etl’état glycémique (glycémie et HbA1c) ainsi que la compo-sition des HDL.Ces résultats suggèrent que : 1) l’altération du l’effluxdans le diabète de type 2 est indépendant de l’équilibreglycémique ainsi que de la composition HDL en phos-pholipides ; 2) le rétablissement de l’efflux chez les pa-tients DC à des valeurs comparables à celles des témoinspourrait être favorisé par leur hypertriglycéridémie géné-rant des particules de prébéta-HDL, connues par leurpouvoir élevé à capter le cholestérol à partir des cellulespériphériques.

EFFECTS OF CHOLINERGIC BLOCKADE BY PIRENZEPINE ON INSULIN AND GLUCOSE RESPONSE TO ORAL GLUCOSE IN OBESE PRE-MENOPAUSAL WOMEN C013F. Vignati(1), O. Disoteo(1), G. Di Sacco(1)

(1) Divisione di Endocrinologia, Ospedale Niguarda, piazza Ospedale Maggiore 3 -20162- Milano Italia.e-mail : [email protected]

Parasympathetic nervous system is known to affect in-sulin secretion in animal and in humans. Pirenzepine, aselective muscarinic cholinergic antagonist, reducesplasma insulin and plasma glucose responses in normalhumans. We studied the effects of pirenzepine onplasma insulin and glucose responses to standard (75g)oral glucose tolerance test (OGTT) in 6 obese pre-meno-pausal women (BMI range=30,50-32,68Kg/m2, agerange 28-35-years). Patients underwent, in random se-quence after an overnight fast and on two separate oc-casions, OGTT alone or OGTT preceded by pirenzepine100mg, 60 minutes before starting OGTT. Blood sampleswere collected at –30min and 0min and, subsequently,every 15 minutes for 2 hours.

Results: The mean insulin response to OGTT (expressed asarea under the curve, AUC) was significantly reduced afterpirenzepine administration (insulin AUC=7297±3160mcU/120min vs 10913±3290 p<0.05). After pirenzepine insulin

levels were significantly reduced at time -30 (10.2±5mcU/mL vs 14.8±6.2; p<0.01) and insulin and glucose levelswere both significantly reduced at time 0’(11.8±4.9mcU/mL vs 15.2±6.2; p<0.05 and 85.8±10mg/dL vs 91.5±13.7;p<0.02 respectively) in comparison to the control day. Intwo patients we also measured plasma glucagon-like pep-tide (GLP-1) levels and in both cases a reduced response ofthe hormone after OGTT was observed when the test waspreceded by pirenzepine administration.Conclusions: The present study confirms that the cho-linergic system plays a role in the exaggerated insulin se-cretion in obese subjects. Interestingly the reduction ofinsulin secretion induced by pirenzepine was not fol-lowed by worsening of glucose response to OGTT. Thisfinding might be consistent with the existence of indi-rect mechanisms, probably involving GLP-1 secretion pa-thways.479 — 23/01/04 — Federico1074855390.

PLASMA AMINO ACID PATTERN CAN BE INFLUENCED BY AGE AND DIABETES C014G. Di Sacco(1), R. Accinni(2), C. Della Noce(2), F. Muratori(1)

(1) Divisione di Endocrinologia, Ospedale Niguarda, Milan, Italy.e-mail : [email protected](2) Institute of Clinical Physiology, CNR Sezione di Milano, Niguarda Hospital, Milan, Italy.

It is well known that age and diabetes may affect pro-tein metabolism, but few data are so far available onplasma amino acid pattern (AAP) in these conditions.The present study was performed to search for differences,

if any, in AAP in adult young and elderly subjects withor without diabetes.We measured, by HPLC, morning plasma amino acidpattern after an overnight fast, in 4 groups of subjects.